MondayJan 10, 2022 12:33 pm

Nowigence Inc. (NOWG) Proprietary Platform — Pluaris — Poised for Growth in AI-Focused New Year

Global crisis accelerated adoption of analytics and AI; momentum will continue into the 2020s. An estimated 86% of survey respondents say that AI is becoming a “mainstream technology.” Pluaris generates an annotated data feed based on specified topics of interest. Accelerated by the global pandemic, the adoption of artificial intelligence (“AI”) is gaining steam, with 2022 projected to be a year when AI becomes a “mainstream technology” (https://ibn.fm/ulgS4). Nowigence Inc. (NOWG), a fast-growing SaaS (Software-as-a-Service) company that has developed an innovative, ready-to-use artificial intelligence (“AI”) platform called Pluaris(TM), is establishing a stronghold in the burgeoning AI space.  “When it comes…

Continue Reading

MondayJan 10, 2022 12:18 pm

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: ONFA) Announces Completion of Target-Based Model in Its AI-Driven Drug Discovery Program

The AI-driven drug discovery program uses not only artificial intelligence but also machine learning, which is a relatively new concept and is continuously expanding The use of artificial intelligence in the drug development space may help eliminate or reduce the manual operations that a company typically must undergo to identify and make necessary improvements to drugs  The new model will allow the company to rapidly screen billions of structures promoting near term patent filings for novel psychedelic molecules  Mydecine has already been able to eliminate unsuccessful candidates early on with the use of this technology Mydecine’s primary focus is the…

Continue Reading

MondayJan 10, 2022 12:02 pm

Congressman Calls for Liberalized Access to Psilocybin; Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) Positions for Growth Within Psychedelics Sector

Congressman Earl Blumenauer recently wrote to his peers, urging them to petition the DEA to permit terminally ill patients to use psilocybin as part of their treatment Although 41 states permit terminal patients to try investigational drugs, psilocybin continues to be banned by the DEA Change seems to be coming within the sector as evidenced by its decriminalization in cities such as Denver and Oakland Delic Corp has positioned itself as a leading psychedelic wellness platform, with business interests in ketamine infusion clinics, media, event management, and psilocybin research In mid-December, Representative Earl Blumenauer circulated an open letter to his…

Continue Reading

MondayJan 10, 2022 11:37 am

As Bitcoin Marks 13th Anniversary, LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Works Toward Widespread Cryptocurrency Adoption via Lightning Network PaaS Offering

Bitcoin saw many different milestones during 2021, including surpassing $1 trillion in market value LQwD launched its PaaS, lqwd.tech, on November 17, amidst the Adopting Bitcoin – A Lightning Summit in El Salvador The Lightning Network has seen explosive growth since January 2021 LQwD’s corporate and operational update highlights several of the company’s achievements regarding funding, agreements to drive Bitcoin adoption and own Bitcoin deployment to procure additional Lightning Network nodes and provide liquidity for the platform Bitcoin was officially launched 13 years ago on January 3, 2009, by Satoshi Nakamoto, the pseudonym used by the person or persons who…

Continue Reading

MondayJan 10, 2022 11:10 am

StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) Welcomes Addition to Leadership Team Amid Mining Option Advances for 2022

StraightUp has hired experienced commodities entrepreneur and economic geologist Rod Husband as its new CEO as it enters 2022 in an expansionist phase Mineral property exploration company StraightUp Resources is building excitement for several properties it has optioned in the gold-producing region of Ontario’s famed Red Lake Mining District StraightUp also acquired a mine in the historic Bullfrog Boom area surrounding Beatty, Nevada during recent months The company recently added a listing on the OTCQB Venture Market and eligibility for electronic clearing and settlement of its transactions through the Depository Trust Company The company has completed heliborne investigations at three…

Continue Reading

MondayJan 10, 2022 10:14 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) CEO Participation in Upcoming Events Recognizes Company Expertise

CEO to participate in panel discussion, fireside chat focusing on psychedelics The company is engineering next-generation psychedelic molecules as it works to transform the mental health treatment landscape CYBN is implementing a three-pillar strategy Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing psychedelics to therapeutics, is gaining recognition as a leader in the psychedelic space. Evidence of this can be seen in the Cybin CEO’s upcoming participation in two virtual investor conferences (https://ibn.fm/1zAF4). The company announced that CEO Doug Drysdale has been invited to participate in a panel discussion titled "Psychedelics: More Than Just a Trip" during…

Continue Reading

MondayJan 10, 2022 9:53 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives Independent Review Board Approval for Its Most Ambitious, Comprehensive Human Study Yet

Lexaria has received approval from the Independent Review Board for its DehydraTECH-CBD Human Clinical HYPER-H21-4 study The approval signals the company has taken the appropriate steps to protect the rights and welfare of human subjects participating in its fourth human study HYPER-H21-4 should "de-risk" outcomes prior to Lexaria's planned entry into regulatory pathways for the use of DehydraTECH-CBD to treat hypertension and perhaps other forms of cardiovascular disease Previous studies – HYPER-H21-1 and HYPER-H21-2 – have evidenced a remarkable, rapid, and safe drop in blood pressure with DehydraTECH-CBD A little less than two months after Lexaria Bioscience (NASDAQ: LEXX) announced…

Continue Reading

FridayJan 07, 2022 9:30 am

Flora Growth Corp. (NASDAQ: FLGC), a 2021 Year Review

2021 marked the year when Flora Growth held its IPO - the company’s common shares commenced trading on the Nasdaq Capital Market in May under the ticker symbol “FLGC" It also marked the year when the company ventured into the European market, as well as other key regions such as Mexico Significant acquisitions for the 2021 calendar year included Koch & Gsell, Vessel Brand Inc., and GMP-Certified Laboratory Flora Growth also made notable appointments to its executive leadership as well as its board of directors Flora Growth (NASDAQ: FLGC) had an impressive year in 2021, highlighted by the company’s Initial…

Continue Reading

FridayJan 07, 2022 9:30 am

GreenBox POS (NASDAQ: GBOX) Is ‘One to Watch’

GreenBox POS reported $8 million in revenue for Q3 2021 on $540 million processed transaction volume GreenBox’s guidance for FY2022 forecasts processing volume of at least $4.9 billion The company’s planned spinoff of its coyni smart contract token technology is expected to accelerate revenue growth GreenBox shareholders will have an opportunity to benefit from dividends in the coyni spin off IPO The company’s Board of Directors recently approved a share buy-back program GreenBox POS (NASDAQ: GBOX) is an emerging financial technology company leveraging proprietary security and token technology to build customized payment solutions for business. The company’s mission is to build…

Continue Reading

FridayJan 07, 2022 9:00 am

Mullen Automotive Inc. (NASDAQ: MULN) Receives Rave Reviews Following Debut at LA Auto Show; Mullen FIVE RS Aims to Be World’s Fastest EV

Mullen Automotive launched the Mullen FIVE EV Crossover at the recent LA Auto Show, with the vehicle winning the auto show’s ZEVA(R) award for top all-electric SUV The Mullen FIVE has seen a spike in popularity following its debut, with the carmaker recently opting to lift the initial reservation limit to 25,000 vehicles The future Mullen FIVE’s RS is being modeled to usurp Tesla Model S Plaid’s title as the world’s fastest EV, with the ability to accelerate from 0-62 mph in a mere 1.9 seconds Mullen Automotive has recently entered a partnership with Germany's ARRK to support the engineering…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered